Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human beta IG-H3 Antibody, R&D Systems™

Mouse Monoclonal Antibody
Supplier: R&D Systems MAB2935
This item is not returnable.
View return policy
Description
Beta Ig-h3/TGFBI Monoclonal specifically detects Beta Ig-h3/TGFBI in Human samples. It is validated for Western Blot, ELISA Capture (Matched Antibody Pair).Specifications
Beta Ig-h3/TGFBI | |
Monoclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
beta IGH3, Beta ig-h3, BIGH3EBMD, CDB1, CDG2, CDGG1transforming growth factor, beta-induced, 68kD, CSD, CSD1, CSD2, CSD3, Kerato-epithelin, LCD1, RGD-CAP, RGD-containing collagen-associated protein, TGFBI, TGFBIP, transforming growth factor, beta-induced, 68kDa, transforming growth factor-beta-induced protein ig-h3 | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
7045 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG1 |
Western Blot, ELISA | |
348506 | |
Western Blot 1 ug/mL, ELISA Capture (Matched Antibody Pair) 2-8 ug/mL | |
Q15582 | |
TGFBI | |
Mouse myeloma cell line NS0-derived recombinant human beta IG-H3 Gly24-His683 Accession # Q15582 | |
500 μg | |
Primary | |
Detects human beta IG-H3 in ELISAs and Western blots. In Western blots, this antibody does not cross-react with recombinant mouse beta IG-H3. | |
Human | |
Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction